The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Open accessAbstract
Tumor cell migration and invasion play fundamental roles in cancer metastasis. The mammalian target of rapamycin (mTOR), a highly conserved and ubiquitously expressed serine/threonine (Ser/Thr) kinase, is a central regulator of cell growth, proliferation, differentiation and survival. Recent studies have shown that mTOR also plays a critical role in the regulation of tumor cell motility, invasion and cancer metastasis. Current knowledge indicates that mTOR functions as two distinct complexes, mTORC1 and mTORC2. mTORC1 phosphorylates p70 S6 kinase (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1), and regulates cell growth, proliferation, survival and motility. mTORC2 phosphorylates Akt, protein kinase C α (PKCα) and the focal adhesion proteins, and controls the activities of the small GTPases (RhoA, Cdc42 and Rac1), and regulates cell survival and the actin cytoskeleton. Here we briefly review recent knowledge of mTOR complexes and the role of mTOR signaling in tumor cell migration and invasion. We also discuss recent efforts about the mechanism by which rapamycin, a specific inhibitor of mTOR, inhibits cell migration, invasion and cancer metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Cell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Focal adhesion kinase: in command and control of cell motility.
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,335
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,114
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Genomic analysis of metastasis reveals an essential role for RhoC
Clark, E. A., Golub, T. R., Lander, E. S., & Hynes, R. O. (2000) · Nature · doi:10.1038/35020106 · Cited by 1,445
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
Gingras, A.-C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,343
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Pause, A., Belsham, G. J., Gingras, A.-C., Donzé, O., Lin, T.-A., Lawrence, J. C., & Sonenberg, N. (1994) · Nature · doi:10.1038/371762a0 · Cited by 1,239
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,138
Maira, S.-M., Stauffer, F., Brueggen, J., Furet, P., Schnell, C., Fritsch, C., Brachmann, S., Chène, P., De Pover, A., Schoemaker, K., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0017 · Cited by 1,134
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071
Regulation of cap-dependent translation by eIF4E inhibitory proteins
Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 970
Kim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961
SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Choi, J., Chen, J., Schreiber, S. L., & Clardy, J. (1996) · Science · doi:10.1126/science.273.5272.239 · Cited by 929
The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors
Beck, T., & Hall, M. N. (1999) · Nature · doi:10.1038/45287 · Cited by 924
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907
Isolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., & Greenberg, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.952-965.2001 · Cited by 860
Immunoregulatory functions of mTOR inhibition
Thomson, A. W., Turnquist, H. R., & Raimondi, G. (2009) · Nature Reviews Immunology · doi:10.1038/nri2546 · Cited by 847
Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., & Hall, M. N. (1993) · Cell · doi:10.1016/0092-8674(93)90144-f · Cited by 834
Phosphorylation and Activation of p70 s6k by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826
Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., & Tsukita, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.391 · Cited by 779
Pende, M., Um, S. H., Mieulet, V., Sticker, M., Goss, V. L., Mestan, J., Mueller, M., Fumagalli, S., Kozma, S. C., & Thomas, G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3112-3124.2004 · Cited by 742
Drosophila S6 Kinase: A Regulator of Cell Size
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 717
mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s
Frias, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W., Sculley, T., Carr, S. A., & Sabatini, D. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.001 · Cited by 695
PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation
Lin, T.-A., Kong, X., Haystead, T. A. J., Pause, A., Belsham, G., Sonenberg, N., & Lawrence, J. C. (1994) · Science · doi:10.1126/science.7939721 · Cited by 671
Rapamycin-Induced Inhibition of the 70-Kilodalton S6 Protein Kinase
Price, D. J., Grove, J. R., Calvo, V., Avruch, J., & Bierer, B. E. (1992) · Science · doi:10.1126/science.1380182 · Cited by 666
The biology of cell locomotion within three-dimensional extracellular matrix
Friedl, P., & Br�cker, E.-B. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050498 · Cited by 656
Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
Jefferies, H. B., Reinhard, C., Kozma, S. C., & Thomas, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4441 · Cited by 623
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition
Irie, H. Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S., & Brugge, J. S. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505087 · Cited by 589
The TOR signaling cascade regulates gene expression in response to nutrients
Cardenas, M. E., Cutler, N. S., Lorenz, M. C., Di Como, C. J., & Heitman, J. (1999) · Genes & Development · doi:10.1101/gad.13.24.3271 · Cited by 582
Alessi, D. R., Kozlowski, M. T., Weng, Q.-P., Morrice, N., & Avruch, J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70037-5 · Cited by 574
Lamouille, S., & Derynck, R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611146 · Cited by 572
TOR signalling in bugs, brain and brawn
Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 565
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4947 · Cited by 556
Paxillin: a focal adhesion-associated adaptor protein
Schaller, M. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204786 · Cited by 541
Yang, Q., & Guan, K.-L. (2007) · Cell Research · doi:10.1038/cr.2007.64 · Cited by 535
Regulation of eIF-4E BP1 Phosphorylation by mTOR
Hara, K., Yonezawa, K., Kozlowski, M. T., Sugimoto, T., Andrabi, K., Weng, Q.-P., Kasuga, M., Nishimoto, I., & Avruch, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26457 · Cited by 527
Hardwick, J. S., Kuruvilla, F. G., Tong, J. K., Shamji, A. F., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14866 · Cited by 522
PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle Checkpoints
Keith, C. T., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.270.5233.50 · Cited by 518
Rapamycin inhibits vascular smooth muscle cell migration.
Poon, M., Marx, S. O., Gallo, R., Badimon, J. J., Taubman, M. B., & Marks, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119038 · Cited by 511
Role of MAP kinase in tumor progression and invasion
Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 509
Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., & Slamon, D. J. (2003) · PubMed · Cited by 507
PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding
Wang, L., Harris, T. E., Roth, R. A., & Lawrence, J. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702376200 · Cited by 494
RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.
Chiu, M. I., Katz, H., & Berlin, V (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12574 · Cited by 481
Identification of Protor as a novel Rictor-binding component of mTOR complex-2
Pearce, L. R., Huang, X., Boudeau, J., Pawłowski, R., Wullschleger, S., Deak, M., Ibrahim, A. F. M., Gourlay, R., Magnuson, M. A., & Alessi, D. R. (2007) · Biochemical Journal · doi:10.1042/bj20070540 · Cited by 464
TOR signalling and control of cell growth
Thomas, G., & Hall, M. N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80078-6 · Cited by 462
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)
García-Martínez, J. M., Moran, J., Clarke, R. G., Gray, A., Cosulich, S. C., Chresta, C. M., & Alessi, D. R. (2009) · Biochemical Journal · doi:10.1042/bj20090489 · Cited by 455
Pearson, R. B., Dennis, P. B., Han, J. W., Williamson, N. A., Kozma, S. C., Wettenhall, R. E., & Thomas, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00212.x · Cited by 443
Rapamycin and mTOR kinase inhibitors
Ballou, L. M., & Lin, R. Z. (2008) · Journal of Chemical Biology · doi:10.1007/s12154-008-0003-5 · Cited by 442
SIGNALING TO THE ACTIN CYTOSKELETON
Schmidt, A., & Hall, M. N. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.305 · Cited by 440
Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., & Gibbons, J. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080249 · Cited by 420
Akt Blocks Breast Cancer Cell Motility and Invasion through the Transcription Factor NFAT
Yoeli-Lerner, M., Yiu, G. K., Rabinovitz, I., Erhardt, P., Jauliac, S., & Toker, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.033 · Cited by 407
Chan, M. M.-Y., Huang, H.-I., Fenton, M. R., & Fong, D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00114-2 · Cited by 398
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
Soukas, A. A., Kane, E. A., Carr, C. E., Melo, J. A., & Ruvkun, G. (2009) · Genes & Development · doi:10.1101/gad.1775409 · Cited by 380
A Signaling Pathway to Translational Control
Brown, E. J., & Schreiber, S. L. (1996) · Cell · doi:10.1016/s0092-8674(00)80125-7 · Cited by 364
Hosoi, H., Dilling, M. B., Shikata, T., Liu, L. N., Shu, L., Ashmun, R. A., Germain, G. S., Abraham, R. T., & Houghton, P. J. (1999) · PubMed · Cited by 356
Terada, N., Patel, H. R., Takase, K., Kohno, K., Nairn, A. C., & Gelfand, E. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11477 · Cited by 353
Activity of rapamycin (AY-22,989) against transplanted tumors.
ENG, C. P., SEHGAL, S. N., & VEZINA, C. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1231 · Cited by 351
Chen, J., Wang, Q., Fu, X., Huang, X., Chen, X., Cao, L., Chen, L., Tan, H., Li, W., Bi, J., et al. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00449.x · Cited by 342
Immunopurified Mammalian Target of Rapamycin Phosphorylates and Activates p70 S6 Kinase α in Vitro
Isotani, S., Hara, K., Tokunaga, C., Inoue, H., Avruch, J., & Yonezawa, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34493 · Cited by 336
Yu, K., Toral-Barza, L., Shi, C., Zhang, W.-G., Lucas, J., Shor, B., Kim, J., Verheijen, J., Curran, K., Malwitz, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0299 · Cited by 330
Targeting the mTOR signaling network in cancer
Chiang, G. G., & Abraham, R. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.001 · Cited by 327
Boulay, A., Zumstein-Mecker, S., Stephan, C., Beuvink, I., Zilbermann, F., Haller, R., Tobler, S., Heusser, C., O’Reilly, T., Stolz, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3554-2 · Cited by 318
Roberts, N., Kloos, B., Cassella, M., Podgrabinska, S., Persaud, K., Wu, Y., Pytowski, B., & Skobe, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1843 · Cited by 315
Cafferkey, R., Young, P. R., McLaughlin, M. M., Bergsma, D. J., Koltin, Y., Sathe, G. M., Faucette, L., Eng, W. K., Johnson, R. K., & Livi, G. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6012 · Cited by 309
Schmidt, A., Bickle, M., Beck, T., & Hall, M. N. (1997) · Cell · doi:10.1016/s0092-8674(00)81893-0 · Cited by 300
4E-BP3, a New Member of the Eukaryotic Initiation Factor 4E-binding Protein Family
Poulin, F., Gingras, A.-C., Olsen, H., Chevalier, S., & Sonenberg, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14002 · Cited by 300
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
Wolpin, B. M., Hezel, A. F., Abrams, T., Blaszkowsky, L. S., Meyerhardt, J. A., Chan, J. A., Enzinger, P. C., Allen, B., Clark, J. W., Ryan, D. P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9514 · Cited by 297
4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle
Shah, O. J., Anthony, J. C., Kimball, S. R., & Jefferson, L. S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e715 · Cited by 286
Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K
Kozma, S. C., & Thomas, G. (2002) · BioEssays · doi:10.1002/bies.10031 · Cited by 284
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1
Yang, D.-Q., & Kastan, M. B. (2000) · Nature Cell Biology · doi:10.1038/35046542 · Cited by 279
Molecular principles of cancer invasion and metastasis (Review)
Efferth (2009) · International Journal of Oncology · doi:10.3892/ijo_00000214 · Cited by 279
Lin, J., Lalani, A. S., Harding, T. C., Gonzalez, M., Wu, W.-W., Luan, B., Tu, G. H., Koprivnikar, K., VanRoey, M. J., He, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0408 · Cited by 269
The ATRs, ATMs, and TORs Are Giant HEAT Repeat Proteins
Perry, J., & Kleckner, N. (2003) · Cell · doi:10.1016/s0092-8674(03)00033-3 · Cited by 268
TOR2 is required for organization of the actin cytoskeleton in yeast
Schmidt, A., Kunz, J., & Hall, M. N. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13780 · Cited by 262
Gould, K. L., Bretscher, A., Esch, F. S., & Hunter, T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08598.x · Cited by 259
Curcumin inhibits the mammalian target of rapamycin‐mediated signaling pathways in cancer cells
Beevers, C. S., Li, F., Liu, L., & Huang, S. (2006) · International Journal of Cancer · doi:10.1002/ijc.21932 · Cited by 256
Self-citationMasri, J., Bernath, A., Martin, J., Jo, O. D., Vartanian, R., Funk, A., & Gera, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2223 · Cited by 253
Attoub, S., Noe, V., Pirola, L., Bruyneel, E., Chastre, E., Mareel, M., Wymann, M. P., & Gespach, C. (2000) · The FASEB Journal · doi:10.1096/fj.00-0162 · Cited by 235
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy1
Luan, F. L., Hojo, M., Maluccio, M., Yamaji, K., & Suthanthiran, M. (2002) · Transplantation · doi:10.1097/00007890-200205270-00008 · Cited by 235
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J., & Meyuhas, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8101-8113.2002 · Cited by 228
Rizzieri, D. A., Feldman, E., DiPersio, J. F., Gabrail, N., Stock, W., Strair, R., Rivera, V. M., Albitar, M., Bedrosian, C. L., & Giles, F. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1372 · Cited by 222
Integrins and GTPases in tumour cell growth, motility and invasion
Keely, P., Parise, L., & Juliano, R. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01219-1 · Cited by 218
Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma
Wan, X., Mendoza, A., Khanna, C., & Helman, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3135 · Cited by 216
Tor2 Directly Phosphorylates the AGC Kinase Ypk2 To Regulate Actin Polarization
Kamada, Y., Fujioka, Y., Suzuki, N. N., Inagaki, F., Wullschleger, S., Loewith, R., Hall, M. N., & Ohsumi, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7239-7248.2005 · Cited by 210
Grewe, M., Gansauge, F., Schmid, R. M., Adler, G., & Seufferlein, T. T. W. (1999) · PubMed · Cited by 209
Luan, F. L., Ding, R., Sharma, V. K., James Chon, W., Lagman, M., & Suthanthiran, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00805.x · Cited by 206
Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis
Huber, S., Bruns, C. J., Schmid, G., Hermann, P. C., Conrad, C., Niess, H., Huss, R., Graeb, C., Jauch, K.-W., Heeschen, C., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002112 · Cited by 203
Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex
Beevers, C. S., Chen, L., Liu, L., Luo, Y., Webster, N. J. G., & Huang, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2367 · Cited by 203
Self-citationWoo, S.-Y., Kim, D.-H., Jun, C.-B., Kim, Y.-M., Haar, E. V., Lee, S.-I., Hegg, J. W., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704343200 · Cited by 202
New antitumor substances of natural origin
Douros, J., & Suffness, M. (1981) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(81)80006-0 · Cited by 202
Coordinate regulation of translation by the PI 3-kinase and mTOR pathways
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)86001-8 · Cited by 199
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
Jiang, H., Shang, X., Wu, H., Gautam, S. C., Al‐Holou, S. N., Li, C., Kuo, J., Zhang, L., & Chopp, M. (2009) · PubMed · Cited by 195
Abraham, R. T. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80172-6 · Cited by 192
Rictor/TORC2 Regulates Caenorhabditis elegans Fat Storage, Body Size, and Development through sgk-1
Jones, K. T., Greer, E. R., Pearce, D., & Ashrafi, K. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000060 · Cited by 191
dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1
Radimerski, T., Montagne, J., Rintelen, F., Stocker, H., van der Kaay, J., Downes, C. P., Hafen, E., & Thomas, G. (2002) · Nature Cell Biology · doi:10.1038/ncb763 · Cited by 190
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways
Liu, L., Li, F., Cardelli, J. A., Martin, K. A., Blenis, J., & Huang, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209691 · Cited by 189
Self-citationTemsirolimus, an Inhibitor of Mammalian Target of Rapamycin
Rini, B. I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4719 · Cited by 183
Role for p27 Kip1 in Vascular Smooth Muscle Cell Migration
Sun, J., Marx, S. O., Chen, H.-J., Poon, M., Marks, A. R., & Rabbani, L. E. (2001) · Circulation · doi:10.1161/01.cir.103.24.2967 · Cited by 179
Saitoh, M., Pullen, N., Brennan, P., Cantrell, D., Dennis, P. B., & Thomas, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201745200 · Cited by 177
The p70 S6 Kinase Integrates Nutrient and Growth Signals to Control Translational Capacity
Avruch, J., Belham, C., Weng, Q.-P., Hara, K., & Yonezawa, K. (2001) · Progress in Molecular and Subcellular Biology · doi:10.1007/978-3-642-56688-2_5 · Cited by 175
Seufferlein, T., & Rozengurt, E. (1996) · PubMed · Cited by 169
Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
Liu, L., Chen, L., Chung, J., & Huang, S. (2008) · Oncogene · doi:10.1038/onc.2008.137 · Cited by 162
Self-citationP-Rex1 Links Mammalian Target of Rapamycin Signaling to Rac Activation and Cell Migration
Hernández-Negrete, I., Carretero-Ortega, J., Rosenfeldt, H., Hernández-Garciía, R., Calderón-Salinas, J. V., Reyes-Cruz, G., Gutkind, J. S., & Vázquez-Prado, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703771200 · Cited by 161
Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.
Johnson, S. M., Gulhati, P., Arrieta, I., Wang, X., Uchida, T., Gao, T., & Evers, B. M. (2009) · PubMed · Cited by 161
Molckovsky, A., & Siu, L. L. (2008) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-1-20 · Cited by 159
Rho proteins induce metastatic properties in vivo
Peso, L. D., Hernández-Alcoceba, R., Embade, N., Carnero, A., Esteve, P., Paje, C., & Lacal, J. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201499 · Cited by 158
Kobayashi, S., Kishimoto, T., Kamata, S., Otsuka, M., Miyazaki, M., & Ishikura, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00439.x · Cited by 157
Nakamura, Y., Yogosawa, S., Izutani, Y., Watanabe, H., Otsuji, E., & Sakai, T. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-100 · Cited by 149
Fadri‐Moskwik, M., Daquinag, A. C., Wang, S., Xue, T., & Kunz, J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0564 · Cited by 148
Genome‐wide lethality screen identifies new PI4,5P2 effectors that regulate the actin cytoskeleton
Audhya, A., Loewith, R., Parsons, A. B., Gao, L., Tabuchi, M., Zhou, H., Boone, C. M., Hall, M. N., & Emr, S. D. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600384 · Cited by 140
Self-citationDilling, M. B., Dias, P., Shapiro, D. N., Germain, G. S., Johnson, R. K., & Houghton, P. J. (1994) · PubMed · Cited by 138
Role of the p70S6K pathway in regulating the actin cytoskeleton and cell migration
Berven, L. A., Willard, F. S., & Crouch, M. F. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.032 · Cited by 137
A single gene encodes two isoforms of the p70 S6 kinase: activation upon mitogenic stimulation.
Reinhard, C., Thomas, G., & Kozma, S. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.4052 · Cited by 117
Zhou, H. Y., & Wong, A. S. T. (2006) · Endocrinology · doi:10.1210/en.2005-1404 · Cited by 117
Self-citationRapamycin inhibits GM‐CSF‐induced neutrophil migration
Gómez-Cambronero, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00828-7 · Cited by 110
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells
de Brito, P. M., Devillard, R., Nègre‐Salvayre, A., Almeida, L. M., Dinis, T. C. P., Salvayre, R., & Augè, N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.011 · Cited by 107
Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer
Boffa, D. J., Luan, F., Thomas, D. A., Yang, H., Sharma, V. K., Lagman, M., & Suthanthiran, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0629-3 · Cited by 105
Amato, R., D’Antona, L., Porciatti, G., Agosti, V., Menniti, M., Rinaldo, C., Costa, N., Bellacchio, E., Mattarocci, S., Fuiano, G., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0525-5 · Cited by 103
Dual Requirement for a Newly Identified Phosphorylation Site in p70 s6k
Moser, B. A., Dennis, P. B., Pullen, N., Pearson, R. B., Williamson, N. A., Wettenhall, R. E. H., Kozma, S. C., & Thomas, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5648 · Cited by 103
Kong, D., Banerjee, S., Huang, W., Li, Y., Wang, Z., Kim, H.-R. C., & Sarkar, F. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3241 · Cited by 102
Ogawa, T., Tokuda, M., Tomizawa, K., Matsui, H., Itano, T., Konishi, R., Nagahata, S., & Hatase, O. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9118 · Cited by 92
Regulation of Ribosomal S6 Kinase 2 by Mammalian Target of Rapamycin
Park, I., Bachmann, R. A., Shirazi, H., & Chen, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204080200 · Cited by 89
Busch, S., Renaud, S. J., Schleußner, E., Graham, C. H., & Markert, U. R. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.01.026 · Cited by 87
Inhibitory Effect of Rapamycin on Corneal Neovascularization In Vitro and In Vivo
Kwon, Y.-S., Hong, H. S., Kim, J. C., Shin, J., & Son, Y. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0753 · Cited by 85
A Putative Sirolimus (Rapamycin) Effector Protein
Chen, Y. Q., Chen, H. H., Rhoad, A. E., Warner, L., Caggiano, T. J., Failli, A., Zhang, H. Z., Hsiao, C. L., Nakanishi, K., & Molnar-Kimber, K. L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2140 · Cited by 82
Rho-Regulatory Proteins in Breast Cancer Cell Motility and Invasion
Lin, M. T., & van Golen, K. L. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018424.43445.f3 · Cited by 82
Regulation of IGF-I Receptor Signaling in Tumor Cells
O’Connor, R. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814166 · Cited by 81
Hsp70 associates with Rictor and is required for mTORC2 formation and activity
Martin, J., Masri, J., Bernath, A., Nishimura, R. N., & Gera, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.086 · Cited by 79
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2021) · Cell · doi:10.1016/j.cell.2021.03.060 · Cited by 79
mTORC2 regulates PGE2-mediated endothelial cell survival and migration
Dada, S., Demartines, N., & Dormond, O. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.154 · Cited by 64
Matsuo, M., Yamada, S., Koizumi, K., Sakurai, H., & Saiki, I. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.04.024 · Cited by 62
Li, D. (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000212 · Cited by 59
Takizawa, H., Kondo, K., Fujino, H., Kenzaki, K., Miyoshi, T., Sakiyama, S., & Tangoku, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603209 · Cited by 57
Targeting the mTOR Pathway Using Deforolimus in Cancer Therapy
Mahalingam, D., Sankhala, K. K., Mita, A. C., Giles, F. J., & Mita, M. M. (2009) · Future Oncology · doi:10.2217/fon.09.9 · Cited by 48
Resistance to Rapamycin: A Novel Anticancer Drug
Huang, S., & Houghton, P. J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013167315885 · Cited by 46
Self-citationYang, D., Brunn, G. J., & Lawrence, J. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00762-0 · Cited by 46
Wong, A. S. T., Roskelley, C. D., Pelech, S., Miller, D. M., Leung, P. C. K., & Auersperg, N. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.002 · Cited by 45
IL-20 activates human lymphatic endothelial cells causing cell signalling and tube formation
Hammer, T., Tritsaris, K., Hübschmann, M. V., Gibson, J., Nisato, R. E., Pepper, M. S., & Dissing, S. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.02.007 · Cited by 41
Rapamycin Inhibits IGF-1 Stimulated Cell Motility through PP2A Pathway
Liu, L., Chen, L., Luo, Y., Chen, W., Zhou, H., Xu, B., Han, X., Shen, T., & Huang, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010578 · Cited by 40
Self-citationSakakibara, K., Liu, B., Hollenbeck, S., & Kent, K. (2005) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00561.2004 · Cited by 39
Yang, Z., Zhang, L., Li, B., Zhou, Y., Zhang, G., Feng, Z., Zhang, B., Shen, G., & Huang, B. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01412.x · Cited by 38
Cdc42 and Rac1 are necessary for autotaxin‐induced tumor cell motility in A2058 melanoma cells
Jung, I. D., Lee, J., Yun, S. Y., Park, C. G., Choi, W. S., Lee, H. W., Choi, O. H., Han, J. W., & Lee, H. Y. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03698-0 · Cited by 32
Chen, J. Y., Hung, C.-C., Huang, K.-L., Chen, Y., Liu, S.-Y., Chiang, W.-F., Chen, H.-R., Yen, C.-Y., Wu, Y., Ko, J.-Y., et al. (2008) · Neoplasia · doi:10.1593/neo.08854 · Cited by 29
Harwood, F. C., Shu, L., & Houghton, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706173200 · Cited by 25
Silletti, S., Paku, S., & Raz, A. (1997) · Pathology & Oncology Research · doi:10.1007/bf02899927 · Cited by 22
Jackson, J. L., & Young, M. R. I. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1024012000009 · Cited by 11
Simultaneous pancreas-kidney transplantation initial experience
Linhares, M. M., Gonzalez, A. M., Triviño, T., Melaragno, C. S., Moura, R. M. A. M., Garcez, M., de Sá, J. R., Aguiar, W., Succi, T., Barbosa, C., et al. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00328-2 · Cited by 5
Cited by
Rapamycin passes the torch: a new generation of mTOR inhibitors
Benjamin, D., Colombi, M., Moroni, C., & Hall, M. N. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3531 · Cited by 989
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549
“Additionally, AKT can activate mTORC1 by the phosphorylation and inactivation of TSC2 or by the phosphorylation of PRAS40,(152) which affects cell growth, proliferation, survival, and motility.(153) Alternatively, RECK can negatively control two matrix metallopeptidases, MMP-2 and MMP-9, which inhibit angiogenesis and…”
BackgroundmTOR: Role in cancer, metastasis and drug resistance
Murugan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.003 · Cited by 483
Ramchandani, D., Berisa, M., Tavarez, D. A., Li, Z., Miele, M., Bai, Y., Lee, S. B., Ban, Y., Dephoure, N., Hendrickson, R. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27559-z · Cited by 309
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M. C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.652 · Cited by 306
Metadata
- Authors
- Huang, S., & Zhou, H.
- Venue
- Current Protein & Peptide Science
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-02-01
- Volume
- 12
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1389-2037 (ISSN-L)
- OpenAlex
- W1996983679
- Cited by
- 270
- References
- 173
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.